Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Journal of Cardiovascular Pharmacology|January 1, 1989
Antihypertensive, anticalcinotic, and antiarteriosclerotic properties of anipamil, a long-acting new derivative of verapamilM Frey, J Zorn, G Fleckenstein-Grün, et al.Journal of Cardiovascular Pharmacology|August 1, 1995
Progression and regression by verapamil of vitamin D3-induced calcific medial degeneration in coronary arteries of ratsG Fleckenstein-Grün, F Thimm, M Frey, et al.Cardiovascular Drugs and Therapy|August 1, 1990
Excessive mural calcium overload--a predominant causal factor in the development of stenosing coronary plaques in humansA Fleckenstein, M Frey, F Thimm, et al.Basic Research in Cardiology|January 1, 1994
Role of calcium in arteriosclerosis--experimental evaluation of antiarteriosclerotic potencies of Ca antagonists. Study Group for Calcium AntagonismG Fleckenstein-Grün, F Thimm, M Frey, et al.The American Journal of Cardiology|January 30, 1987
Future directions in the use of calcium antagonistsA Fleckenstein, G Fleckenstein-Grün, M Frey, et al.Cell Calcium|April 9, 2001
Ca(2+) entry into primary cultured pig coronary smooth muscle cells after previous store depletion by repetitive P2Y purinoceptor stimulationJ Weirich, L Seiler, M J Hug, et al.Angiology|March 1, 1988
Restriction by nitrendipine of excessive concentration of free intracellular calcium ions in ventricular myocardium of hypertensive ratsR Gasser, M Frey, Y K Byon, et al.Endocrine-Related Cancer|February 15, 2001
Hormonal interactions in endometrial cancerG Emons, G Fleckenstein, B Hinney, et al.Journal of Cardiovascular Pharmacology|January 1, 1994
Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterationsG Fleckenstein-Grün, F Thimm, A Czirfuzs, et al.Zeitschrift Fur Kardiologie|January 1, 1984
[Specific mechanism of action of calcium antagonists in the neutralization of experimental coronary spasms]G Fleckenstein-Grün, Y J Makita, Y K Byon, et al.Pageof 4